Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in LYEL — Lyell Immunopharma, Inc.

CIK 19617 NEW YORK, NY
Back to LYEL Full portfolio

Position in LYEL

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$67,383
+$37,935 QoQ
Shares Held
4,796
+226.7% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 87 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 19% Shared 0% None 81%

Common Shares in LYEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,254,031 across 424 Biotechnology names. LYEL ranks #290 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,517,600 $3,237,487,438
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,774,199 $2,353,364,036
3 INSM
INSMED Inc
 10,428,170 $1,111,851,478
4 ALNY
Alnylam Pharmaceuticals, Inc.
 2,675,517 $805,410,876
5 RVMD
Revolution Medicines, Inc.
 3,298,066 $617,661,794
6 RYTM
Rhythm Pharmaceuticals, Inc.
 2,652,746 $294,534,385
7 JAZZ
Jazz Pharmaceuticals plc
 1,160,786 $279,714,596
8 QURE
uniQure N.V.
 4,867,755 $224,208,791

All Filings in LYEL

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $67,383 4,796
2026-03-31 $29,448 1,468
2025-12-31 $49,740 1,616
2025-09-30 $7,957 490
2025-06-30 $29,781 3,369
2025-03-31 $104,720 194,651
2024-12-31 $277,288 433,265
2024-09-30 $133,513 96,749
2024-06-30 $140,856 97,143
2024-03-31 $1,459,805 654,622
2023-12-31 $315,431 162,594
2023-09-30 $374,057 254,461
2023-06-30 $748,491 235,375
2023-03-31 $1,475,016 625,007
2022-12-31 $1,985,349 572,147
2022-09-30 $3,811,540 519,992
2022-06-30 $3,437,174 527,174
2022-03-31 $2,617,939 518,404
2021-12-31 $3,594,076 464,351
2021-09-30 $5,062,665 342,072